<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6080</number>
    <updateDate>2022-02-08T23:15:55Z</updateDate>
    <updateDateIncludingText>2022-02-08T23:15:55Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2020-03-04</introducedDate>
    <congress>116</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 166, Number 43 (Wednesday, March 4, 2020)][House]From the Congressional Record Online through the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]By Mr. PETERS:H.R. 6080.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H1505]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-03-04T15:01:45Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Mitigating Emergency Drug Shortages Act</title>
        <congress>116</congress>
        <number>2723</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-10-29</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-03-04</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2020-03-04</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2020-03-04</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000608</bioguideId>
        <fullName>Rep. Peters, Scott H. [D-CA-52]</fullName>
        <firstName>Scott</firstName>
        <lastName>Peters</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>H.</middleName>
        <district>52</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>E000179</bioguideId>
        <fullName>Rep. Engel, Eliot L. [D-NY-16]</fullName>
        <firstName>ELIOT</firstName>
        <lastName>ENGEL</lastName>
        <party>D</party>
        <state>NY</state>
        <middleName>L.</middleName>
        <district>16</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>E000215</bioguideId>
        <fullName>Rep. Eshoo, Anna G. [D-CA-18]</fullName>
        <firstName>ANNA</firstName>
        <lastName>ESHOO</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>G.</middleName>
        <district>18</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000558</bioguideId>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <firstName>Brett</firstName>
        <lastName>Guthrie</lastName>
        <party>R</party>
        <state>KY</state>
        <district>2</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001180</bioguideId>
        <fullName>Rep. Schrader, Kurt [D-OR-5]</fullName>
        <firstName>Kurt</firstName>
        <lastName>Schrader</lastName>
        <party>D</party>
        <state>OR</state>
        <district>5</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001157</bioguideId>
        <fullName>Rep. McCaul, Michael T. [R-TX-10]</fullName>
        <firstName>Michael</firstName>
        <lastName>McCaul</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>T.</middleName>
        <district>10</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H001067</bioguideId>
        <fullName>Rep. Hudson, Richard [R-NC-8]</fullName>
        <firstName>Richard</firstName>
        <lastName>Hudson</lastName>
        <party>R</party>
        <state>NC</state>
        <district>8</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001257</bioguideId>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <firstName>Gus</firstName>
        <lastName>Bilirakis</lastName>
        <party>R</party>
        <state>FL</state>
        <middleName>M.</middleName>
        <district>12</district>
        <sponsorshipDate>2020-03-04</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000302</bioguideId>
        <fullName>Rep. Joyce, John [R-PA-13]</fullName>
        <firstName>John</firstName>
        <lastName>Joyce</lastName>
        <party>R</party>
        <state>PA</state>
        <district>13</district>
        <sponsorshipDate>2020-03-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Government studies and investigations</name>
        </item>
        <item>
          <name>Health information and medical records</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Manufacturing</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-03-04</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2021-01-28T15:11:24Z</updateDate>
        <text><![CDATA[ <p><b>Preventing Drug Shortages Act</b></p> <p>This bill expands existing manufacturer reporting requirements related to shortages of life-saving drugs and contains other related provisions.</p> <p>The bill requires a manufacturer of an active pharmaceutical ingredient of a life-saving drug to notify the Food and Drug Administration (FDA) of an interruption that is likely to lead to a meaningful disruption in the ingredient's supply, whereas under current law this requirement generally applies only to the manufacturer of a life-saving drug that faces a supply disruption.</p> <p>The notification must contain specified information, including any alternative sources for the ingredient.</p> <p>The bill also requires a manufacturer of a life-saving drug or an active pharmaceutical ingredient for such a drug to include in its annual product registration the specific facilities where the drug or ingredient is manufactured. The FDA may also require the manufacturer to conduct periodic risk assessments to address vulnerabilities in its supply chain. </p> <p>The Government Accountability Office shall report to Congress on the FDA's intra-agency coordination in assessing drug shortage risks.</p>]]></text>
      </summary>
    </summaries>
    <title>Preventing Drug Shortages Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Preventing Drug Shortages Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to reduce drug shortages, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Preventing Drug Shortages Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2020-03-04T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr6080ih/xml/BILLS-116hr6080ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-03-04</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
